Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Hatami

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Frontiers in Microbiology|January 1, 2021
Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMRSama Rezasoltani, Abbas Yadegar, Behzad Hatami, et al.
Clinical Laboratory|April 11, 2019
Circulating miR-625 as an Emerging Biomarker for Liver CirrhosisMohabbat Ghaempoor, Ehsan Arefian, Seyed R Mohebbi, et al.
Gastroenterology and Hepatology From Bed to Bench|July 30, 2025
Prevalence of primary sclerosing cholangitis (PSC) in Iranian adult patients with inflammatory bowel disease (IBD) or liver disorders: systematic review and meta-analysisEhsaneh Taheri, Behzad Hatami, Fatemeh Baghalha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 1, 2023
Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodelingArezou Azizsoltani, Behzad Hatami, Mohammad Reza Zali, et al.
Pathology, Research and Practice|October 5, 2023
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progressionMeysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, et al.
International Immunopharmacology|May 11, 2023
Human Wharton's jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosisBahare Niknam, Kaveh Baghaei, Seyed Mahmoud Hashemi, et al.
Molecular Biology Research Communications|January 31, 2023
Investigating the association of toll-like receptor 9 rs5743836, rs352140, and rs187084 gene polymorphisms and their mRNA levels with different hepatic fibrosis stages of non-alcoholic fatty liver patients compared to healthy controlsAzadeh Rezaie, Meysam Nasiri, Behzad Hatami, et al.
Cell Biology International|October 2, 2022
The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosisAli Malmir, Shirin Farivar, Ramazan Rezaei, et al.
International Immunopharmacology|April 18, 2025
Limosilactobacillus fermentum role in combination with human mesenchymal stem cell-derived secretome: A novel approach to alleviate inflammation in NASH pathogenesisSeyedeh Kosar Mahmoudi, Shahrokh Abdolahi, Parastoo Saniee, et al.
Gastroenterology and Hepatology From Bed to Bench|February 19, 2019
Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver diseaseSaeede Saadati, Azita Hekmatdoost, Behzad Hatami, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Microbiology|January 1, 2021
Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMRSama Rezasoltani, Abbas Yadegar, Behzad Hatami, et al.
Clinical Laboratory|April 11, 2019
Circulating miR-625 as an Emerging Biomarker for Liver CirrhosisMohabbat Ghaempoor, Ehsan Arefian, Seyed R Mohebbi, et al.
Gastroenterology and Hepatology From Bed to Bench|July 30, 2025
Prevalence of primary sclerosing cholangitis (PSC) in Iranian adult patients with inflammatory bowel disease (IBD) or liver disorders: systematic review and meta-analysisEhsaneh Taheri, Behzad Hatami, Fatemeh Baghalha, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 1, 2023
Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodelingArezou Azizsoltani, Behzad Hatami, Mohammad Reza Zali, et al.
Pathology, Research and Practice|October 5, 2023
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progressionMeysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, et al.
International Immunopharmacology|May 11, 2023
Human Wharton's jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosisBahare Niknam, Kaveh Baghaei, Seyed Mahmoud Hashemi, et al.
Molecular Biology Research Communications|January 31, 2023
Investigating the association of toll-like receptor 9 rs5743836, rs352140, and rs187084 gene polymorphisms and their mRNA levels with different hepatic fibrosis stages of non-alcoholic fatty liver patients compared to healthy controlsAzadeh Rezaie, Meysam Nasiri, Behzad Hatami, et al.
Cell Biology International|October 2, 2022
The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosisAli Malmir, Shirin Farivar, Ramazan Rezaei, et al.
International Immunopharmacology|April 18, 2025
Limosilactobacillus fermentum role in combination with human mesenchymal stem cell-derived secretome: A novel approach to alleviate inflammation in NASH pathogenesisSeyedeh Kosar Mahmoudi, Shahrokh Abdolahi, Parastoo Saniee, et al.
Gastroenterology and Hepatology From Bed to Bench|February 19, 2019
Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver diseaseSaeede Saadati, Azita Hekmatdoost, Behzad Hatami, et al.
Pageof 9